Gene2info is a biotechnology company founded in 2018 as a collaboration between Multigen Health Services and Idea Technology Solutions. With headquarters in Boston, USA and operational teams in Türkiye, the company has quickly expanded its footprint to 20 countries across 4 continents.
Focused on rare diseases, Gene2info offers an innovative, end-to-end genetic diagnostic solution. Their notable offerings include standardized test kits and the award-winning Gene2Var AI-Powered Bioinformatics Platform. This platform drastically reduces diagnostic costs and expedites genetic analysis from weeks to mere hours.
As the pioneering and sole provider of a globally integrated genetic diagnostic service, Gene2info is positioned as a transformative player in the biotechnology industry. Despite its groundbreaking achievements, the company has not reported its last investment details, which may present both an opportunity and a point of interest for potential investors keen on advancing global healthcare solutions.